US 10100020
Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
granted A61KA61K31/155A61K31/165
Quick answer
US patent 10100020 (Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases) held by United Kingdom Research and Innovation expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Kingdom Research and Innovation
- Grant date
- Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/155, A61K31/165, A61K31/216, A61K31/44